China's Health Security Administration said on Sunday that talks to include Pfizer's Paxlovid in the latest drug list for basic state health insurance did not succeed.
The talks fell through was due to Pfizer's high quotation for Paxlovid. Pfizer did not immeditately respond to a request to comment.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
A health assessment could help you reach your health goalsWith half of Americans looking to improve their exercise routine, Intermountain Healthcare is offering a health assessment to get a personalized plan to help you reach your goals.
Leer más »
Health Insurance 101: Understanding Health Insurance TermsCopays Deductibles Out-of-network In-network What does it all mean? 🤔 Health insurance terms can be confusing — but understanding them can help you make the most of your coverage. Check out our list of common health insurance terms.
Leer más »
Health companies use ever-advancing tech to make health management more accessibleAt CES 2023 in Las Vegas, health companies showcased how new technologies are making health management easier.
Leer más »
The World Health Organization thinks China might not be telling the truth after allYou would be hard-pressed to find an organization more useless than the United Nations, and there may be no U.N. institution that is more embarrassing than the World Health Organization.
Leer más »
Bad sign for TikTok security talks with Biden team as consultant hires delayedTikTok has put a hold on hiring consultants to help the company fulfill a pending security agreement with White House officials, the latest sign of tension in the Chinese-operated company's efforts to adapt to U.S. security concerns.
Leer más »
Pfizer in talks with China to market COVID-19 antiviral treatment: ReportChina is reportedly in discussions with Pfizer to secure a license for the U.S. drugmaker's COVID-19 antiviral Paxlovid amid a surge in cases in the mainland.
Leer más »